MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

||
||

Income Overview

Net Income
-$23,758K
EPS
-$8.75
Unit: Thousand (K) dollars
Income Statement
2026-06-30
Research and development
21,355
General and administrative
3,315
Total operating expenses
24,670
Loss from operations
-24,670
Interest income, net
915
Other expense, net
3
Total other income, net
912
Net loss
-23,758
Basic EPS
-8.75
Diluted EPS
-8.75
Basic Average Shares
2,713,696
Diluted Average Shares
2,713,696
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Interest income, net$915K Net loss-$23,758K Total other income,net$912K Other expense, net$3K Loss from operations-$24,670K Total operatingexpenses$24,670K Research and development$21,355K General andadministrative$3,315K

BlossomHill Therapeutics, Inc. (BLSM)

BlossomHill Therapeutics, Inc. (BLSM)